Wednesday 14 October 2026
Export MOH’s income statement to Excel — free account
Molina Healthcare, Inc
MOH Healthcare Healthcare Plans
Molina Healthcare, Inc’s revenue for fiscal 2025 (year ended December 2025) was $45.4 billion, up 11.7% from fiscal 2024. In the quarter to June 2026, revenue fell 4.84%, EPS fell 75.0%, free cash flow grew 5.81% and total debt rose 10.9%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
209.87
5.51
+2.70%
Follow MOH
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
11.85 | 20.27 | 39.44 | 0.00 |
P/S ratio |
0.23 | 0.20 | 0.15 | 0.26 | |
P/FCF ratio |
0.00 | 0.00 | 27.03 | 43.12 | |
P/Operating CF |
(80.37) | (30.75) | 6.27 | (39.75) | |
P/B ratio |
2.40 | 2.25 | 1.66 | 2.80 | |
Price to Tangible BV |
5.05 | 4.89 | 3.41 | 5.59 | |
EV/Sales |
0.12 | 0.11 | 0.03 | 0.15 | |
EV/EBITDA |
3.60 | 5.00 | 2.44 | 18.20 | |
EV/Operating CF |
(11.88) | (9.13) | 4.22 | 18.49 | |
EV/FCF |
(9.54) | (7.68) | 6.00 | 24.91 | |
Quick Ratio |
1.60 | 1.60 | 1.55 | 1.61 | |
Current Ratio |
1.68 | 1.69 | 1.63 | 1.68 | |
Net Debt/EBITDA |
(25.25) | 36.49 | (43.48) | (26.82) | |
Debt/Assets |
24.54% | 25.38% | 24.08% | 24.70% | |
Debt/Equity |
0.92 | 0.97 | 0.97 | 0.95 | |
Asset Turnover |
2.83 | 2.91 | 2.75 | 2.76 | |
Operating CF/Net income |
(1.58) | 1.86 | 77.29 | (4.90) | |
Capex/Depreciation |
(0.84) | 0.02 | (0.69) | (0.75) | |
Interest Coverage |
2.80 | (3.12) | 1.54 | 2.69 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
6.35% | 6.99% | 7.22% | 6.66% | |
Intangible Assets out of Total Assets |
0.14 | 0.14 | 0.13 | 0.13 | |
Share Based Compensation of Revenue |
(0.03%) | 0.18% | 0.31% | 0.24% | |
Graham Net Nets |
0.10 | 0.10 | 0.15 | 0.09 | |
Graham Number |
170.32 | 121.83 | 78.08 | 0.00 | |
Earnings Yield |
8.44% | 4.93% | 2.54% | (0.08%) | |
Free Cash Flow Yield |
(5.71%) | (6.94%) | 3.70% | 2.32% | |
Revenue per Share |
218.61 | 215.44 | 212.10 | 212.80 | |
Operating CF per Share |
(2.38) | (5.64) | 21.26 | (5.75) | |
Capex per Share |
(0.72) | 0.02 | (0.53) | (0.59) | |
Free Cash Flow per Share |
(3.10) | (5.62) | 20.73 | (6.34) | |
Cash per Share |
160.90 | 156.36 | 181.75 | 174.46 | |
Shareholders Equity per Share |
79.83 | 77.06 | 80.16 | 81.62 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
79.83 | 77.06 | 80.16 | 81.62 | |
Free Cash Flow |
(163.00) | (297.00) | 1,055.00 | (324.00) | |
Working Capital |
5,071.00 | 5,072.00 | 5,138.00 | 5,228.00 | |
Capital Expenditures |
(38.00) | 1.00 | (27.00) | (30.00) | |
Net Current Asset Value |
1,045.00 | 949.00 | 1,015.00 | 1,096.00 | |
EV/EBIT |
4.14 | 6.25 | 3.50 | 33.25 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Operating Income |
7.59 | 11.73 | 15.74 | 57.57 | |
| Other line items | |||||
Average Receivables |
3,387.00 | 3,416.00 | 3,455.50 | 3,675.00 | |
Average Payables |
1,169.50 | 1,212.00 | 1,140.00 | 1,126.00 | |
Average Assets |
15,728.00 | 15,597.00 | 16,388.50 | 16,106.00 | |
Average Common Equity |
4,480.50 | 4,282.50 | 4,195.00 | 4,387.00 |
Columns are period end dates